nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiagabine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.144	0.463	CbGbCtD
Tiagabine—CYP3A4—Progesterone—uterine cancer	0.0952	0.307	CbGbCtD
Tiagabine—CYP3A4—Etoposide—uterine cancer	0.0426	0.137	CbGbCtD
Tiagabine—CYP3A4—Doxorubicin—uterine cancer	0.0291	0.0936	CbGbCtD
Tiagabine—Malaise—Etoposide—uterine cancer	0.000448	0.00065	CcSEcCtD
Tiagabine—Dermatitis bullous—Doxorubicin—uterine cancer	0.000448	0.000649	CcSEcCtD
Tiagabine—Face oedema—Epirubicin—uterine cancer	0.000446	0.000647	CcSEcCtD
Tiagabine—Vertigo—Etoposide—uterine cancer	0.000446	0.000647	CcSEcCtD
Tiagabine—Leukopenia—Etoposide—uterine cancer	0.000445	0.000645	CcSEcCtD
Tiagabine—Abdominal pain—Dactinomycin—uterine cancer	0.000443	0.000642	CcSEcCtD
Tiagabine—Body temperature increased—Dactinomycin—uterine cancer	0.000443	0.000642	CcSEcCtD
Tiagabine—Hypoglycaemia—Doxorubicin—uterine cancer	0.000438	0.000636	CcSEcCtD
Tiagabine—Mood swings—Epirubicin—uterine cancer	0.000438	0.000635	CcSEcCtD
Tiagabine—Loss of consciousness—Etoposide—uterine cancer	0.000437	0.000633	CcSEcCtD
Tiagabine—Ataxia—Epirubicin—uterine cancer	0.000435	0.000631	CcSEcCtD
Tiagabine—Cough—Etoposide—uterine cancer	0.000433	0.000629	CcSEcCtD
Tiagabine—Dehydration—Epirubicin—uterine cancer	0.00043	0.000624	CcSEcCtD
Tiagabine—Hyponatraemia—Doxorubicin—uterine cancer	0.000429	0.000623	CcSEcCtD
Tiagabine—Hypertension—Etoposide—uterine cancer	0.000429	0.000622	CcSEcCtD
Tiagabine—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	0.000428	0.000621	CcSEcCtD
Tiagabine—Osteoarthritis—Doxorubicin—uterine cancer	0.000428	0.000621	CcSEcCtD
Tiagabine—Diplopia—Doxorubicin—uterine cancer	0.000428	0.000621	CcSEcCtD
Tiagabine—Liver function test abnormal—Epirubicin—uterine cancer	0.000427	0.000619	CcSEcCtD
Tiagabine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000426	0.000619	CcSEcCtD
Tiagabine—Dry skin—Epirubicin—uterine cancer	0.000424	0.000615	CcSEcCtD
Tiagabine—Chest pain—Etoposide—uterine cancer	0.000423	0.000613	CcSEcCtD
Tiagabine—Orthostatic hypotension—Epirubicin—uterine cancer	0.000422	0.000613	CcSEcCtD
Tiagabine—Affect lability—Doxorubicin—uterine cancer	0.000421	0.000611	CcSEcCtD
Tiagabine—Migraine—Doxorubicin—uterine cancer	0.000421	0.000611	CcSEcCtD
Tiagabine—Hypokalaemia—Epirubicin—uterine cancer	0.000421	0.00061	CcSEcCtD
Tiagabine—Discomfort—Etoposide—uterine cancer	0.000418	0.000606	CcSEcCtD
Tiagabine—Face oedema—Doxorubicin—uterine cancer	0.000413	0.000599	CcSEcCtD
Tiagabine—Hypersensitivity—Dactinomycin—uterine cancer	0.000413	0.000599	CcSEcCtD
Tiagabine—Gastritis—Epirubicin—uterine cancer	0.000409	0.000594	CcSEcCtD
Tiagabine—Confusional state—Etoposide—uterine cancer	0.000409	0.000593	CcSEcCtD
Tiagabine—Muscular weakness—Epirubicin—uterine cancer	0.000408	0.000591	CcSEcCtD
Tiagabine—Mood swings—Doxorubicin—uterine cancer	0.000405	0.000588	CcSEcCtD
Tiagabine—Infection—Etoposide—uterine cancer	0.000403	0.000584	CcSEcCtD
Tiagabine—Ataxia—Doxorubicin—uterine cancer	0.000402	0.000583	CcSEcCtD
Tiagabine—Asthenia—Dactinomycin—uterine cancer	0.000402	0.000583	CcSEcCtD
Tiagabine—Influenza—Epirubicin—uterine cancer	0.0004	0.00058	CcSEcCtD
Tiagabine—Asthma—Epirubicin—uterine cancer	0.0004	0.00058	CcSEcCtD
Tiagabine—Dysphagia—Epirubicin—uterine cancer	0.0004	0.00058	CcSEcCtD
Tiagabine—Dehydration—Doxorubicin—uterine cancer	0.000398	0.000577	CcSEcCtD
Tiagabine—Thrombocytopenia—Etoposide—uterine cancer	0.000397	0.000576	CcSEcCtD
Tiagabine—Tachycardia—Etoposide—uterine cancer	0.000396	0.000574	CcSEcCtD
Tiagabine—Liver function test abnormal—Doxorubicin—uterine cancer	0.000395	0.000573	CcSEcCtD
Tiagabine—Dry skin—Doxorubicin—uterine cancer	0.000392	0.000569	CcSEcCtD
Tiagabine—Hyperhidrosis—Etoposide—uterine cancer	0.000392	0.000568	CcSEcCtD
Tiagabine—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000391	0.000567	CcSEcCtD
Tiagabine—Hypokalaemia—Doxorubicin—uterine cancer	0.000389	0.000565	CcSEcCtD
Tiagabine—Angina pectoris—Epirubicin—uterine cancer	0.000389	0.000565	CcSEcCtD
Tiagabine—Anorexia—Etoposide—uterine cancer	0.000386	0.000561	CcSEcCtD
Tiagabine—Bronchitis—Epirubicin—uterine cancer	0.000384	0.000557	CcSEcCtD
Tiagabine—Diarrhoea—Dactinomycin—uterine cancer	0.000383	0.000556	CcSEcCtD
Tiagabine—Hypotension—Etoposide—uterine cancer	0.000379	0.000549	CcSEcCtD
Tiagabine—Gastritis—Doxorubicin—uterine cancer	0.000379	0.000549	CcSEcCtD
Tiagabine—Muscular weakness—Doxorubicin—uterine cancer	0.000377	0.000547	CcSEcCtD
Tiagabine—Dysuria—Epirubicin—uterine cancer	0.000374	0.000542	CcSEcCtD
Tiagabine—Asthma—Doxorubicin—uterine cancer	0.00037	0.000536	CcSEcCtD
Tiagabine—Dysphagia—Doxorubicin—uterine cancer	0.00037	0.000536	CcSEcCtD
Tiagabine—Influenza—Doxorubicin—uterine cancer	0.00037	0.000536	CcSEcCtD
Tiagabine—Pollakiuria—Epirubicin—uterine cancer	0.000369	0.000535	CcSEcCtD
Tiagabine—Photosensitivity reaction—Epirubicin—uterine cancer	0.000365	0.000529	CcSEcCtD
Tiagabine—Paraesthesia—Etoposide—uterine cancer	0.000364	0.000528	CcSEcCtD
Tiagabine—Weight increased—Epirubicin—uterine cancer	0.000364	0.000528	CcSEcCtD
Tiagabine—Weight decreased—Epirubicin—uterine cancer	0.000361	0.000524	CcSEcCtD
Tiagabine—Dyspnoea—Etoposide—uterine cancer	0.000361	0.000524	CcSEcCtD
Tiagabine—Hyperglycaemia—Epirubicin—uterine cancer	0.00036	0.000523	CcSEcCtD
Tiagabine—Somnolence—Etoposide—uterine cancer	0.00036	0.000523	CcSEcCtD
Tiagabine—Angina pectoris—Doxorubicin—uterine cancer	0.00036	0.000522	CcSEcCtD
Tiagabine—Pneumonia—Epirubicin—uterine cancer	0.000358	0.00052	CcSEcCtD
Tiagabine—Vomiting—Dactinomycin—uterine cancer	0.000356	0.000517	CcSEcCtD
Tiagabine—Bronchitis—Doxorubicin—uterine cancer	0.000356	0.000516	CcSEcCtD
Tiagabine—Rash—Dactinomycin—uterine cancer	0.000353	0.000512	CcSEcCtD
Tiagabine—Decreased appetite—Etoposide—uterine cancer	0.000352	0.000511	CcSEcCtD
Tiagabine—Renal failure—Epirubicin—uterine cancer	0.00035	0.000508	CcSEcCtD
Tiagabine—Fatigue—Etoposide—uterine cancer	0.000349	0.000507	CcSEcCtD
Tiagabine—Neuropathy peripheral—Epirubicin—uterine cancer	0.000349	0.000507	CcSEcCtD
Tiagabine—Stomatitis—Epirubicin—uterine cancer	0.000347	0.000504	CcSEcCtD
Tiagabine—Pain—Etoposide—uterine cancer	0.000347	0.000503	CcSEcCtD
Tiagabine—Constipation—Etoposide—uterine cancer	0.000347	0.000503	CcSEcCtD
Tiagabine—Urinary tract infection—Epirubicin—uterine cancer	0.000346	0.000502	CcSEcCtD
Tiagabine—Conjunctivitis—Epirubicin—uterine cancer	0.000346	0.000502	CcSEcCtD
Tiagabine—Dysuria—Doxorubicin—uterine cancer	0.000346	0.000502	CcSEcCtD
Tiagabine—Sweating—Epirubicin—uterine cancer	0.000342	0.000495	CcSEcCtD
Tiagabine—Pollakiuria—Doxorubicin—uterine cancer	0.000342	0.000495	CcSEcCtD
Tiagabine—Haematuria—Epirubicin—uterine cancer	0.00034	0.000493	CcSEcCtD
Tiagabine—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000337	0.00049	CcSEcCtD
Tiagabine—Weight increased—Doxorubicin—uterine cancer	0.000336	0.000488	CcSEcCtD
Tiagabine—Epistaxis—Epirubicin—uterine cancer	0.000336	0.000487	CcSEcCtD
Tiagabine—Weight decreased—Doxorubicin—uterine cancer	0.000334	0.000485	CcSEcCtD
Tiagabine—Sinusitis—Epirubicin—uterine cancer	0.000334	0.000485	CcSEcCtD
Tiagabine—Feeling abnormal—Etoposide—uterine cancer	0.000334	0.000485	CcSEcCtD
Tiagabine—Hyperglycaemia—Doxorubicin—uterine cancer	0.000333	0.000484	CcSEcCtD
Tiagabine—Nausea—Dactinomycin—uterine cancer	0.000333	0.000483	CcSEcCtD
Tiagabine—Pneumonia—Doxorubicin—uterine cancer	0.000332	0.000481	CcSEcCtD
Tiagabine—Gastrointestinal pain—Etoposide—uterine cancer	0.000331	0.000481	CcSEcCtD
Tiagabine—Renal failure—Doxorubicin—uterine cancer	0.000324	0.00047	CcSEcCtD
Tiagabine—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000323	0.000469	CcSEcCtD
Tiagabine—Urticaria—Etoposide—uterine cancer	0.000322	0.000467	CcSEcCtD
Tiagabine—Haemoglobin—Epirubicin—uterine cancer	0.000321	0.000466	CcSEcCtD
Tiagabine—Stomatitis—Doxorubicin—uterine cancer	0.000321	0.000466	CcSEcCtD
Tiagabine—Rhinitis—Epirubicin—uterine cancer	0.000321	0.000465	CcSEcCtD
Tiagabine—Abdominal pain—Etoposide—uterine cancer	0.00032	0.000465	CcSEcCtD
Tiagabine—Body temperature increased—Etoposide—uterine cancer	0.00032	0.000465	CcSEcCtD
Tiagabine—Conjunctivitis—Doxorubicin—uterine cancer	0.00032	0.000465	CcSEcCtD
Tiagabine—Urinary tract infection—Doxorubicin—uterine cancer	0.00032	0.000465	CcSEcCtD
Tiagabine—Haemorrhage—Epirubicin—uterine cancer	0.00032	0.000464	CcSEcCtD
Tiagabine—Hypoaesthesia—Epirubicin—uterine cancer	0.000318	0.000462	CcSEcCtD
Tiagabine—Pharyngitis—Epirubicin—uterine cancer	0.000317	0.00046	CcSEcCtD
Tiagabine—Sweating—Doxorubicin—uterine cancer	0.000316	0.000458	CcSEcCtD
Tiagabine—Oedema peripheral—Epirubicin—uterine cancer	0.000315	0.000457	CcSEcCtD
Tiagabine—Haematuria—Doxorubicin—uterine cancer	0.000314	0.000456	CcSEcCtD
Tiagabine—Epistaxis—Doxorubicin—uterine cancer	0.000311	0.000451	CcSEcCtD
Tiagabine—Sinusitis—Doxorubicin—uterine cancer	0.000309	0.000449	CcSEcCtD
Tiagabine—Visual impairment—Epirubicin—uterine cancer	0.000308	0.000447	CcSEcCtD
Tiagabine—Hypersensitivity—Etoposide—uterine cancer	0.000299	0.000433	CcSEcCtD
Tiagabine—Tinnitus—Epirubicin—uterine cancer	0.000298	0.000433	CcSEcCtD
Tiagabine—Haemoglobin—Doxorubicin—uterine cancer	0.000297	0.000431	CcSEcCtD
Tiagabine—Rhinitis—Doxorubicin—uterine cancer	0.000297	0.00043	CcSEcCtD
Tiagabine—Haemorrhage—Doxorubicin—uterine cancer	0.000296	0.000429	CcSEcCtD
Tiagabine—Hypoaesthesia—Doxorubicin—uterine cancer	0.000294	0.000427	CcSEcCtD
Tiagabine—Pharyngitis—Doxorubicin—uterine cancer	0.000294	0.000426	CcSEcCtD
Tiagabine—Oedema peripheral—Doxorubicin—uterine cancer	0.000292	0.000423	CcSEcCtD
Tiagabine—Asthenia—Etoposide—uterine cancer	0.000291	0.000422	CcSEcCtD
Tiagabine—Chills—Epirubicin—uterine cancer	0.000287	0.000416	CcSEcCtD
Tiagabine—Pruritus—Etoposide—uterine cancer	0.000287	0.000416	CcSEcCtD
Tiagabine—Visual impairment—Doxorubicin—uterine cancer	0.000285	0.000414	CcSEcCtD
Tiagabine—Alopecia—Epirubicin—uterine cancer	0.000283	0.00041	CcSEcCtD
Tiagabine—Diarrhoea—Etoposide—uterine cancer	0.000277	0.000402	CcSEcCtD
Tiagabine—Tinnitus—Doxorubicin—uterine cancer	0.000276	0.0004	CcSEcCtD
Tiagabine—Flatulence—Epirubicin—uterine cancer	0.000274	0.000398	CcSEcCtD
Tiagabine—Tension—Epirubicin—uterine cancer	0.000273	0.000396	CcSEcCtD
Tiagabine—Dysgeusia—Epirubicin—uterine cancer	0.000273	0.000395	CcSEcCtD
Tiagabine—Nervousness—Epirubicin—uterine cancer	0.00027	0.000392	CcSEcCtD
Tiagabine—Back pain—Epirubicin—uterine cancer	0.000269	0.000391	CcSEcCtD
Tiagabine—Dizziness—Etoposide—uterine cancer	0.000268	0.000389	CcSEcCtD
Tiagabine—Muscle spasms—Epirubicin—uterine cancer	0.000268	0.000388	CcSEcCtD
Tiagabine—Chills—Doxorubicin—uterine cancer	0.000266	0.000385	CcSEcCtD
Tiagabine—Alopecia—Doxorubicin—uterine cancer	0.000261	0.000379	CcSEcCtD
Tiagabine—Ill-defined disorder—Epirubicin—uterine cancer	0.000258	0.000375	CcSEcCtD
Tiagabine—Vomiting—Etoposide—uterine cancer	0.000258	0.000374	CcSEcCtD
Tiagabine—Anaemia—Epirubicin—uterine cancer	0.000257	0.000373	CcSEcCtD
Tiagabine—Agitation—Epirubicin—uterine cancer	0.000256	0.000371	CcSEcCtD
Tiagabine—Rash—Etoposide—uterine cancer	0.000256	0.000371	CcSEcCtD
Tiagabine—Dermatitis—Etoposide—uterine cancer	0.000255	0.00037	CcSEcCtD
Tiagabine—Headache—Etoposide—uterine cancer	0.000254	0.000368	CcSEcCtD
Tiagabine—Flatulence—Doxorubicin—uterine cancer	0.000254	0.000368	CcSEcCtD
Tiagabine—Tension—Doxorubicin—uterine cancer	0.000253	0.000367	CcSEcCtD
Tiagabine—Dysgeusia—Doxorubicin—uterine cancer	0.000252	0.000366	CcSEcCtD
Tiagabine—Malaise—Epirubicin—uterine cancer	0.000251	0.000364	CcSEcCtD
Tiagabine—Nervousness—Doxorubicin—uterine cancer	0.00025	0.000363	CcSEcCtD
Tiagabine—Vertigo—Epirubicin—uterine cancer	0.00025	0.000363	CcSEcCtD
Tiagabine—Syncope—Epirubicin—uterine cancer	0.00025	0.000362	CcSEcCtD
Tiagabine—Leukopenia—Epirubicin—uterine cancer	0.000249	0.000362	CcSEcCtD
Tiagabine—Back pain—Doxorubicin—uterine cancer	0.000249	0.000361	CcSEcCtD
Tiagabine—Muscle spasms—Doxorubicin—uterine cancer	0.000248	0.000359	CcSEcCtD
Tiagabine—Palpitations—Epirubicin—uterine cancer	0.000246	0.000357	CcSEcCtD
Tiagabine—Loss of consciousness—Epirubicin—uterine cancer	0.000245	0.000355	CcSEcCtD
Tiagabine—Cough—Epirubicin—uterine cancer	0.000243	0.000352	CcSEcCtD
Tiagabine—Nausea—Etoposide—uterine cancer	0.000241	0.000349	CcSEcCtD
Tiagabine—Hypertension—Epirubicin—uterine cancer	0.00024	0.000349	CcSEcCtD
Tiagabine—Ill-defined disorder—Doxorubicin—uterine cancer	0.000239	0.000347	CcSEcCtD
Tiagabine—Anaemia—Doxorubicin—uterine cancer	0.000238	0.000345	CcSEcCtD
Tiagabine—Arthralgia—Epirubicin—uterine cancer	0.000237	0.000344	CcSEcCtD
Tiagabine—Chest pain—Epirubicin—uterine cancer	0.000237	0.000344	CcSEcCtD
Tiagabine—Myalgia—Epirubicin—uterine cancer	0.000237	0.000344	CcSEcCtD
Tiagabine—Agitation—Doxorubicin—uterine cancer	0.000237	0.000343	CcSEcCtD
Tiagabine—Anxiety—Epirubicin—uterine cancer	0.000236	0.000343	CcSEcCtD
Tiagabine—Discomfort—Epirubicin—uterine cancer	0.000234	0.00034	CcSEcCtD
Tiagabine—Malaise—Doxorubicin—uterine cancer	0.000232	0.000337	CcSEcCtD
Tiagabine—Dry mouth—Epirubicin—uterine cancer	0.000232	0.000336	CcSEcCtD
Tiagabine—Vertigo—Doxorubicin—uterine cancer	0.000231	0.000336	CcSEcCtD
Tiagabine—Syncope—Doxorubicin—uterine cancer	0.000231	0.000335	CcSEcCtD
Tiagabine—Leukopenia—Doxorubicin—uterine cancer	0.000231	0.000334	CcSEcCtD
Tiagabine—Confusional state—Epirubicin—uterine cancer	0.000229	0.000332	CcSEcCtD
Tiagabine—Palpitations—Doxorubicin—uterine cancer	0.000228	0.00033	CcSEcCtD
Tiagabine—Oedema—Epirubicin—uterine cancer	0.000227	0.00033	CcSEcCtD
Tiagabine—Loss of consciousness—Doxorubicin—uterine cancer	0.000226	0.000328	CcSEcCtD
Tiagabine—Infection—Epirubicin—uterine cancer	0.000226	0.000327	CcSEcCtD
Tiagabine—Cough—Doxorubicin—uterine cancer	0.000225	0.000326	CcSEcCtD
Tiagabine—Shock—Epirubicin—uterine cancer	0.000224	0.000324	CcSEcCtD
Tiagabine—Thrombocytopenia—Epirubicin—uterine cancer	0.000222	0.000323	CcSEcCtD
Tiagabine—Hypertension—Doxorubicin—uterine cancer	0.000222	0.000323	CcSEcCtD
Tiagabine—Tachycardia—Epirubicin—uterine cancer	0.000222	0.000322	CcSEcCtD
Tiagabine—Hyperhidrosis—Epirubicin—uterine cancer	0.00022	0.000319	CcSEcCtD
Tiagabine—Chest pain—Doxorubicin—uterine cancer	0.000219	0.000318	CcSEcCtD
Tiagabine—Myalgia—Doxorubicin—uterine cancer	0.000219	0.000318	CcSEcCtD
Tiagabine—Arthralgia—Doxorubicin—uterine cancer	0.000219	0.000318	CcSEcCtD
Tiagabine—Anxiety—Doxorubicin—uterine cancer	0.000219	0.000317	CcSEcCtD
Tiagabine—Discomfort—Doxorubicin—uterine cancer	0.000217	0.000314	CcSEcCtD
Tiagabine—Anorexia—Epirubicin—uterine cancer	0.000217	0.000314	CcSEcCtD
Tiagabine—Dry mouth—Doxorubicin—uterine cancer	0.000214	0.000311	CcSEcCtD
Tiagabine—Hypotension—Epirubicin—uterine cancer	0.000212	0.000308	CcSEcCtD
Tiagabine—Confusional state—Doxorubicin—uterine cancer	0.000212	0.000308	CcSEcCtD
Tiagabine—Oedema—Doxorubicin—uterine cancer	0.00021	0.000305	CcSEcCtD
Tiagabine—Infection—Doxorubicin—uterine cancer	0.000209	0.000303	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000207	0.0003	CcSEcCtD
Tiagabine—Shock—Doxorubicin—uterine cancer	0.000207	0.0003	CcSEcCtD
Tiagabine—Thrombocytopenia—Doxorubicin—uterine cancer	0.000206	0.000299	CcSEcCtD
Tiagabine—Insomnia—Epirubicin—uterine cancer	0.000206	0.000298	CcSEcCtD
Tiagabine—Tachycardia—Doxorubicin—uterine cancer	0.000205	0.000298	CcSEcCtD
Tiagabine—Paraesthesia—Epirubicin—uterine cancer	0.000204	0.000296	CcSEcCtD
Tiagabine—Hyperhidrosis—Doxorubicin—uterine cancer	0.000203	0.000295	CcSEcCtD
Tiagabine—Dyspnoea—Epirubicin—uterine cancer	0.000203	0.000294	CcSEcCtD
Tiagabine—Somnolence—Epirubicin—uterine cancer	0.000202	0.000293	CcSEcCtD
Tiagabine—Anorexia—Doxorubicin—uterine cancer	0.0002	0.000291	CcSEcCtD
Tiagabine—Dyspepsia—Epirubicin—uterine cancer	0.0002	0.00029	CcSEcCtD
Tiagabine—Decreased appetite—Epirubicin—uterine cancer	0.000198	0.000287	CcSEcCtD
Tiagabine—Hypotension—Doxorubicin—uterine cancer	0.000196	0.000285	CcSEcCtD
Tiagabine—Fatigue—Epirubicin—uterine cancer	0.000196	0.000284	CcSEcCtD
Tiagabine—Pain—Epirubicin—uterine cancer	0.000194	0.000282	CcSEcCtD
Tiagabine—Constipation—Epirubicin—uterine cancer	0.000194	0.000282	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000192	0.000278	CcSEcCtD
Tiagabine—Insomnia—Doxorubicin—uterine cancer	0.00019	0.000276	CcSEcCtD
Tiagabine—Paraesthesia—Doxorubicin—uterine cancer	0.000189	0.000274	CcSEcCtD
Tiagabine—Dyspnoea—Doxorubicin—uterine cancer	0.000187	0.000272	CcSEcCtD
Tiagabine—Feeling abnormal—Epirubicin—uterine cancer	0.000187	0.000272	CcSEcCtD
Tiagabine—Somnolence—Doxorubicin—uterine cancer	0.000187	0.000271	CcSEcCtD
Tiagabine—Gastrointestinal pain—Epirubicin—uterine cancer	0.000186	0.00027	CcSEcCtD
Tiagabine—Dyspepsia—Doxorubicin—uterine cancer	0.000185	0.000268	CcSEcCtD
Tiagabine—Decreased appetite—Doxorubicin—uterine cancer	0.000183	0.000265	CcSEcCtD
Tiagabine—Fatigue—Doxorubicin—uterine cancer	0.000181	0.000263	CcSEcCtD
Tiagabine—Urticaria—Epirubicin—uterine cancer	0.000181	0.000262	CcSEcCtD
Tiagabine—Pain—Doxorubicin—uterine cancer	0.00018	0.000261	CcSEcCtD
Tiagabine—Constipation—Doxorubicin—uterine cancer	0.00018	0.000261	CcSEcCtD
Tiagabine—Body temperature increased—Epirubicin—uterine cancer	0.00018	0.000261	CcSEcCtD
Tiagabine—Abdominal pain—Epirubicin—uterine cancer	0.00018	0.000261	CcSEcCtD
Tiagabine—Feeling abnormal—Doxorubicin—uterine cancer	0.000173	0.000251	CcSEcCtD
Tiagabine—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000172	0.000249	CcSEcCtD
Tiagabine—Hypersensitivity—Epirubicin—uterine cancer	0.000167	0.000243	CcSEcCtD
Tiagabine—Urticaria—Doxorubicin—uterine cancer	0.000167	0.000242	CcSEcCtD
Tiagabine—Body temperature increased—Doxorubicin—uterine cancer	0.000166	0.000241	CcSEcCtD
Tiagabine—Abdominal pain—Doxorubicin—uterine cancer	0.000166	0.000241	CcSEcCtD
Tiagabine—Asthenia—Epirubicin—uterine cancer	0.000163	0.000236	CcSEcCtD
Tiagabine—Pruritus—Epirubicin—uterine cancer	0.000161	0.000233	CcSEcCtD
Tiagabine—Diarrhoea—Epirubicin—uterine cancer	0.000155	0.000226	CcSEcCtD
Tiagabine—Hypersensitivity—Doxorubicin—uterine cancer	0.000155	0.000225	CcSEcCtD
Tiagabine—Asthenia—Doxorubicin—uterine cancer	0.000151	0.000219	CcSEcCtD
Tiagabine—Dizziness—Epirubicin—uterine cancer	0.00015	0.000218	CcSEcCtD
Tiagabine—Pruritus—Doxorubicin—uterine cancer	0.000149	0.000216	CcSEcCtD
Tiagabine—Vomiting—Epirubicin—uterine cancer	0.000144	0.00021	CcSEcCtD
Tiagabine—Diarrhoea—Doxorubicin—uterine cancer	0.000144	0.000209	CcSEcCtD
Tiagabine—Rash—Epirubicin—uterine cancer	0.000143	0.000208	CcSEcCtD
Tiagabine—Dermatitis—Epirubicin—uterine cancer	0.000143	0.000208	CcSEcCtD
Tiagabine—Headache—Epirubicin—uterine cancer	0.000142	0.000206	CcSEcCtD
Tiagabine—Dizziness—Doxorubicin—uterine cancer	0.000139	0.000202	CcSEcCtD
Tiagabine—Nausea—Epirubicin—uterine cancer	0.000135	0.000196	CcSEcCtD
Tiagabine—Vomiting—Doxorubicin—uterine cancer	0.000134	0.000194	CcSEcCtD
Tiagabine—Rash—Doxorubicin—uterine cancer	0.000133	0.000192	CcSEcCtD
Tiagabine—Dermatitis—Doxorubicin—uterine cancer	0.000132	0.000192	CcSEcCtD
Tiagabine—Headache—Doxorubicin—uterine cancer	0.000132	0.000191	CcSEcCtD
Tiagabine—Nausea—Doxorubicin—uterine cancer	0.000125	0.000181	CcSEcCtD
